Lucas Svetlana bought SCTX
March 13, 2026 · Form 4 insider transaction
Lucas Svetlana bought 9,547 shares of Scribe Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 136 days after the transaction.
Direction
Acquired (buy-side)
Shares
9,547
Price
$0.00
Total value
N/A
InsiderLucas Svetlana
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 13, 2026
Filing dateJuly 27, 2026
Shares owned after9,547
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Exchange Act in connection with the Issuer's initial public offering, and the transaction is reported herein pursuant to Rule 16a-2(a).; The option is fully vested.